ADT
41
-7
LLY
62
-2
GRMN
42
-3
HPE
61
4
AMGN
26
-5
UA
26
-4
SLB
46
-2
RL
76
-7
MHK
43
-3
LYB
11
-2
CVS
32
-9
CA
24
3
AAP
33
-3
PHM
54
-3
SE
44
-3
EBAY
52
5
LMT
57
7
RSG
47
-7
CCL
58
3
GE
65
3
ADT
41
-7
LLY
62
-2
GRMN
42
-3
HPE
61
4
AMGN
26
-5
UA
26
-4
SLB
46
-2
RL
76
-7
MHK
43
-3
LYB
11
-2
CVS
32
-9
CA
24
3
AAP
33
-3
PHM
54
-3
SE
44
-3
EBAY
52
5
LMT
57
7
RSG
47
-7
CCL
58
3
GE
65
3
Financhill
Back

The Descartes Systems Group, Inc. Vs. Kymera Therapeutics, Inc. Industry Stock Comparison

Buy
80

DSGX
The Descartes Systems Group, Inc.

Last Price:
$92.25
Seasonality Move:
14.57%
Buy
90

KYMR
Kymera Therapeutics, Inc.

Last Price:
$86.57
Seasonality Move:
7.7%
Buy
80
The Descartes Systems Group, Inc. (DSGX) is a Buy

Is The Descartes Systems Group, Inc. a Buy, Sell or Hold?

  • The current The Descartes Systems Group, Inc. [DSGX] share price is $92.39. The Score for DSGX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • DSGX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
90
Kymera Therapeutics, Inc. (KYMR) is a Buy

Is Kymera Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Kymera Therapeutics, Inc. [KYMR] share price is $94.30. The Score for KYMR is 90, which is 80% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

DSGX Stock Price Chart

What is The Descartes Systems Group, Inc.'s stock price today?

  • The The Descartes Systems Group, Inc. share price today is $92.39
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DSGX is experiencing slight selling pressure.

KYMR Stock Price Chart

What is Kymera Therapeutics, Inc.'s stock price today?

  • The Kymera Therapeutics, Inc. share price today is $94.30
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.

DSGX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.22 Buy
Relative Strength Index (14 RSI): 63.48 Buy
Chaikin Money Flow: -301644 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (79.96 - 87.92) Buy
Bollinger Bands (100): (87.6 - 104.2) Sell

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.92 Buy
Relative Strength Index (14 RSI): 86.88 Buy
Chaikin Money Flow: -462379 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (58.8 - 71.72) Buy
Bollinger Bands (100): (43.38 - 63.26) Buy

DSGX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 86.51 Buy
20-day SMA: 83.58 Buy
50-day SMA: 89.45 Buy
200-day SMA: 100.29 Sell
8-day EMA: 88 Buy
20-day EMA: 86.07 Buy
50-day EMA: 89.16 Buy
200-day EMA: 98.04 Sell

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 70 Buy
20-day SMA: 66.61 Buy
50-day SMA: 61.97 Buy
200-day SMA: 44.25 Buy
8-day EMA: 72.36 Buy
20-day EMA: 67.57 Buy
50-day EMA: 61.93 Buy
200-day EMA: 49.42 Buy

The Descartes Systems Group, Inc. Earnings Growth & DSGX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.01 per share, an increase this year of $0.62 per share, and an increase next year of $0.26 per share.

Kymera Therapeutics, Inc. Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.64 per share, and a decrease next year of $0.35 per share.

The Descartes Systems Group, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):